Warning: The NCBI web site requires JavaScript to function. more...
The inhibitory effects of camptothecin, a topoisomerase I inhibitor, on collagen synthesis in fibroblasts from patients with systemic sclerosis.
Czuwara-Ladykowska J, Makiela B, Smith EA, Trojanowska M, Rudnicka L.
Arthritis Res. 2001;3(5):311-8. Epub 2001 Aug 2.
Related citations
Effect of camptothecin on collagen synthesis in fibroblasts from patients with keloid.
Zhang GY, Gao WY, Li X, Yi CG, Zheng Y, Li Y, Xiao B, Ma XJ, Yan L, Lu KH, Han Y, Guo SZ.
Ann Plast Surg. 2009 Jul;63(1):94-9.
Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis.
Distler O, Pap T, Kowal-Bielecka O, Meyringer R, Guiducci S, Landthaler M, Schölmerich J, Michel BA, Gay RE, Matucci-Cerinic M, Gay S, Müller-Ladner U.
Arthritis Rheum. 2001 Nov;44(11):2665-78.
Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: different sensitivity to inhibition between systemic sclerosis and control fibroblasts.
Chizzolini C, Rezzonico R, Ribbens C, Burger D, Wollheim FA, Dayer JM.
Arthritis Rheum. 1998 Nov;41(11):2039-47.
Basic fibroblast growth factor inhibits basal and transforming growth factor-beta induced collagen alpha 2(I) gene expression in scleroderma and normal fibroblasts.
Ichiki Y, Smith EA, LeRoy EC, Trojanowska M.
J Rheumatol. 1997 Jan;24(1):90-5.
Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
Kawaguchi Y, Takagi K, Hara M, Fukasawa C, Sugiura T, Nishimagi E, Harigai M, Kamatani N.
Arthritis Rheum. 2004 Jan;50(1):216-26.
Selective stimulation of collagen synthesis in the presence of costimulatory insulin signaling by connective tissue growth factor in scleroderma fibroblasts.
Gore-Hyer E, Pannu J, Smith EA, Grotendorst G, Trojanowska M.
Arthritis Rheum. 2003 Mar;48(3):798-806.
Role of p38 MAPK in transforming growth factor beta stimulation of collagen production by scleroderma and healthy dermal fibroblasts.
Sato M, Shegogue D, Gore EA, Smith EA, McDermott PJ, Trojanowska M.
J Invest Dermatol. 2002 Apr;118(4):704-11.
Effect of granulocyte macrophage-colony stimulating factor on extracellular matrix deposition by dermal fibroblasts from patients with scleroderma.
Postiglione L, Ladogana P, Montagnani S, di Spigna G, Castaldo C, Turano M, Bruno EM, Di Meglio F, Riccio A, Rossi G.
J Rheumatol. 2005 Apr;32(4):656-64.
Proteasome blockade exerts an antifibrotic activity by coordinately down-regulating type I collagen and tissue inhibitor of metalloproteinase-1 and up-regulating metalloproteinase-1 production in human dermal fibroblasts.
Fineschi S, Reith W, Guerne PA, Dayer JM, Chizzolini C.
FASEB J. 2006 Mar;20(3):562-4. Epub 2006 Jan 12.
Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.
Distler JH, Jüngel A, Huber LC, Schulze-Horsel U, Zwerina J, Gay RE, Michel BA, Hauser T, Schett G, Gay S, Distler O.
Arthritis Rheum. 2007 Jan;56(1):311-22.
Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
Chujo S, Shirasaki F, Kawara S, Inagaki Y, Kinbara T, Inaoki M, Takigawa M, Takehara K.
J Cell Physiol. 2005 May;203(2):447-56.
Differential regulation of transcription and transcript stability of pro-alpha 1(I) collagen and fibronectin in activated fibroblasts derived from patients with systemic scleroderma.
Eckes B, Mauch C, Hüppe G, Krieg T.
Biochem J. 1996 Apr 15;315 ( Pt 2):549-54.
Inhibition of type I collagen gene expression in normal and systemic sclerosis fibroblasts by a specific inhibitor of geranylgeranyl transferase I.
Rosenbloom J, Saitta B, Gaidarova S, Sandorfi N, Rosenbloom JC, Abrams WR, Hamilton AD, Sebti SM, Kucich U, Jimenez SA.
Arthritis Rheum. 2000 Jul;43(7):1624-32.
Gamma-interferon inhibits extracellular matrix synthesis and remodeling in collagen lattice cultures of normal and scleroderma skin fibroblasts.
Gillery P, Serpier H, Polette M, Bellon G, Clavel C, Wegrowski Y, Birembaut P, Kalis B, Cariou R, Maquart FX.
Eur J Cell Biol. 1992 Apr;57(2):244-53.
Constitutively phosphorylated Smad3 interacts with Sp1 and p300 in scleroderma fibroblasts.
Ihn H, Yamane K, Asano Y, Jinnin M, Tamaki K.
Rheumatology (Oxford). 2006 Feb;45(2):157-65. Epub 2005 Nov 30.
Attenuation of collagen production with small interfering RNA of SPARC in cultured fibroblasts from the skin of patients with scleroderma.
Zhou X, Tan FK, Guo X, Arnett FC.
Arthritis Rheum. 2006 Aug;54(8):2626-31.
Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor beta receptors.
Ihn H, Yamane K, Kubo M, Tamaki K.
Arthritis Rheum. 2001 Feb;44(2):474-80.
Inhibition of collagen gene expression in systemic sclerosis dermal fibroblasts by mithramycin.
Sandorfi N, Louneva N, Hitraya E, Hajnoczky G, Saitta B, Jimenez SA.
Ann Rheum Dis. 2005 Dec;64(12):1685-91. Epub 2005 May 18.
Increased transcriptional activities of transforming growth factor beta receptors in scleroderma fibroblasts.
Yamane K, Ihn H, Kubo M, Tamaki K.
Arthritis Rheum. 2002 Sep;46(9):2421-8.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on